LAVA Therapeutics NV
Earnings Surprise
Analysts estimated LVTX earnings of $-0.25 per share this quarter (Q3). LVTX's actual earnings were $-0.27 per share.
LVTX EPS surprise of -8.04%Analysts estimated LVTX earnings of $-0.26 per share this quarter (Q2). LVTX's actual earnings were $-0.32 per share.
LVTX EPS surprise of -22.23%Analysts estimated LVTX earnings of $-0.39 per share this quarter (Q1). LVTX's actual earnings were $-0.13 per share.
LVTX EPS surprise of 66.68%Analysts estimated LVTX earnings of $-0.30 per share this quarter (Q4). LVTX's actual earnings were $-0.14 per share.
LVTX EPS surprise of 53.47%Analysts estimated LVTX earnings of $-0.34 per share this quarter (Q3). LVTX's actual earnings were $-0.46 per share.
LVTX EPS surprise of -36.66%Analysts estimated LVTX earnings of $-0.37 per share this quarter (Q2). LVTX's actual earnings were $-0.31 per share.
LVTX EPS surprise of 15.58%Analysts estimated LVTX earnings of $-0.13 per share this quarter (Q1). LVTX's actual earnings were $-0.02 per share.
LVTX EPS surprise of 84.31%Analysts estimated LVTX earnings of $-0.13 per share this quarter (Q4). LVTX's actual earnings were $-0.24 per share.
LVTX EPS surprise of 88.24%Analysts estimated LVTX earnings of $-0.50 per share this quarter (Q3). LVTX's actual earnings were $-0.34 per share.
LVTX EPS surprise of -31.97%